Introduction

Semaglutide and tirzepatide are two treatments used in medical weight loss programs to support appetite control and metabolic function. While they work in similar ways, there are important differences between them that may influence which option is appropriate for a patient.

What is Semaglutide

Semaglutide is a GLP-1–based treatment designed to support appetite regulation, reduce food intake, and help patients follow structured weight loss programs.

What is Tirzepatide

Tirzepatide is a dual-action treatment that works on both GLP-1 and GIP pathways, helping support appetite control and metabolic function.

Key Differences

Semaglutide:

    •    GLP-1–based mechanism

    •    Supports appetite control

    •    Widely used in medical weight loss

Tirzepatide:

    •    Dual-action (GLP-1 + GIP)

    •    May provide enhanced metabolic support

    •    Designed to support appetite and energy regulation

How They are Used

Both treatments are typically part of a doctor-supervised weight loss program that includes:

    •    Medical evaluation

    •    Personalized dosing approach

    •    Ongoing monitoring

Which One is Right for You

The best option depends on:

    •    Your medical history

    •    Weight loss goals

    •    Provider evaluation

A consultation is required to determine which treatment is appropriate.

Important Considerations?

These treatments are most effective when combined with:

    •    Lifestyle changes

    •    Nutritional support

    •    Ongoing medical supervision